Michael A. Metzger - Mar 14, 2025 Form 4 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Role
Chief Executive Officer, Director
Signature
/s/ Michael A. Metzger
Stock symbol
SNDX
Transactions as of
Mar 14, 2025
Transactions value $
$43,733
Form type
4
Date filed
3/17/2025, 06:01 AM
Previous filing
Mar 6, 2025
Next filing
Apr 2, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNDX Common Stock Options Exercise $43.7K +6.07K +2.02% $7.20 306K Mar 14, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNDX Stock options (Right to buy) Options Exercise $0 +6.07K $0.00 0 Mar 14, 2025 Common Stock 6.07K $7.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is fully vested.